Resilient Lifescience develops a wearable medical device aimed at mitigating opioid overdose fatalities. This system utilizes non-invasive sensing technology to detect Opioid-Induced Respiratory Depression (OIRD). Upon detection, the device automatically triggers an emergency alarm and administers naloxone to the user.
Funding
$830K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
AHFounders
Product
Problem
Opioid overdose is a leading cause of death, often occurring when individuals are alone and unable to receive timely administration of naloxone. Current methods for detecting respiratory depression rely on intervention by another person.
Solution
Resilient Lifescience is developing a wearable medical device designed to automatically detect Opioid-Induced Respiratory Depression (OIRD) using non-invasive sensing technology. Upon detection of OIRD, the device will sound an emergency alarm and automatically administer naloxone. The Resilient System aims to provide a solution for individuals at risk of opioid overdose, particularly when they are alone, by providing automated detection and intervention.
Target Audience
The primary target audience includes individuals who use opioids and are at risk of overdose, as well as their loved ones and caregivers.
Features
- Non-invasive sensing technology for real-time monitoring of respiratory function
- Automated detection of Opioid-Induced Respiratory Depression (OIRD)
- Automatic naloxone administration upon OIRD detection
- Emergency alarm to alert the user and potential bystanders
- Wearable design for continuous monitoring in various settings